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Background: Disruption in cerebrovascular reactivity following traumatic brain injury (TBI)
is a known phenomenon that may hold prognostic value and clinical relevance. Ultimately,
improved knowledge of this process and more robust means of continuous assessment
may lead to advances in precision medicine following TBI. One such method is transcranial
Doppler (TCD), which has been employed to evaluate cerebrovascular reactivity following
injury utilizing a continuous time-series approach.
Objective: The present study undertakes a scoping review of the literature on the
association of continuous time-domain TCD based indices of cerebrovascular
reactivity, with global functional outcomes, cerebral physiologic correlates, and imaging
evidence of lesion change.
Design: Multiple databases were searched from inception to November 2020 for articles
relevant to the association of continuous time-domain TCD based indices of
cerebrovascular reactivity with global functional outcomes, cerebral physiologic
correlates, and imaging evidence of lesion change.
Results: Thirty-six relevant articles were identified. There was significant evidence
supporting an association with continuous time-domain TCD based indices and
functional outcomes following TBI. Indices based on mean flow velocity, as measured
by TCD, were most numerous while more recent studies point to systolic flow velocity-
based indices encoding more prognostic utility. Physiologic parameters such as
intracranial pressure, cerebral perfusion pressure, Carbon Dioxide (CO2) reactivity as
well as more established indices of cerebrovascular reactivity have all been associated with
these TCD based indices. The literature has been concentrated in a few centres and is
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Conclusions: This systematic scoping review of the literature identifies that there is a
substantial body of evidence that cerebrovascular reactivity as measured by time-domain
TCD based indices have prognostic utility following TBI. Indices based on mean flow
velocities have the largest body of literature for their support. However, recent studies
indicate that indices based on systolic flow velocities may contain the most prognostic
utility and more closely follow more established measures of cerebrovascular reactivity. To
a lesser extent, the literature supports some associations between these indices and
cerebral physiologic parameters. These indices provide a more complete picture of the
patient’s physiome following TBI and may ultimately lead to personalized and precise
clinical care. Further validation in multi-institution studies is required before these indices
can be widely adopted clinically.
Keywords: cerebral autoregulation, cerebrovascular reactivity, scoping review, traumatic brain injury, transcranial
Doppler, precision medicine
INTRODUCTION
The disruption of cerebral autoregulation (CA) following
traumatic brain injury (TBI) has been known since the 1970s
(Overgaard and Tweed, 1974; Cold and Jensen, 1978). At that
time, evaluation of CA was cumbersome and involved
perturbation of the patient’s blood pressure while low
frequency measurement of cerebral blood flow (CBF) were
obtained. This meant that assessment of dynamic changes in
CA was limited and thus its utility in precision medicine limited.
Aaslid and colleagues first described transcranial doppler
ultrasound (TCD) in 1982 as a non-invasive means of
evaluating CBF through insonation of flow velocities (FV) in
the basal arteries of the brain (Aaslid et al., 1982). Since then, the
role of TCD in the management of TBI patients has grown
substantially with widespread adoption in the neurocritical
care setting. It has become one of the most commonly utilized
methods for intracranial monitoring in the critically ill TBI
patient, outside of ICP monitoring, and the most popular
non-invasive cerebral monitoring modality for this population.
While direct TCD measures, such as FV, have been measured for
their association with secondary neurologic decline and global
outcomes, derived TCD metrics have been developed to non-
invasively estimate intracranial pressure (ICP), carbon dioxide
(CO2) reactivity and even CA (Gomez et al., 2021).
Unfortunately, early methods of evaluating CA using TCD,
such as the Thigh Cuff Deflation Technique (TCDT) and
Orthostatic Hypotension Test (OHT), were intermittent in
nature since they still depended on induced changes in arterial
blood pressure (ABP) (Aaslid, 1986; Aaslid et al., 1989; Steinmeier
et al., 2002).
TCD was first described as a tool to continuously evaluate CA
following TBI by Czosnyka and colleagues in 1996 (Czosnyka et al.,
1996). In this study, they described a time-domain based mean flow
index (Mx), a continuously updating Pearson correlation coefficient
between the natural fluctuations in cerebral perfusion pressure
(CPP), equal to the difference between ABP and ICP, and mean
FV through themiddle cerebral artery (MCA) asmeasured by TCD.
This method used mean FV as a surrogate measure for CBF with
CPP used as the driving force in order to continuously interrogate
cerebrovascular reactivity. It should be noted that cerebrovascular
reactivity and CA are not synonymous as vascular reactivity can
occur outside the limits of autoregulation (Varsos et al., 2014). Being
a correlation coefficient, Mx ranged from +1 to −1 with a more
negative correlation being associated with intact cerebrovascular
reactivity and a more positive coefficient being associated with
disrupted reactivity. In their study of 82 moderate and severe TBI
patients, they found a correlation between the state of
cerebrovascular reactivity, as measured by Mx, and 6-month
outcomes (Czosnyka et al., 1996). Of note, for metrics to be
designated as a CA measure, it must have some pre-clinical
validation it its ability to measure aspects of the Lassen
autoregulatory curve. To date, TCD-based metrics have not
received such validation. As such, such measures are referred to
as cerebrovascular reactivity metrics, as opposed to CAmeasures, as
the provide surrogate assessments of cerebral vessel vasomotion, but
have yet to be validated as CAmeasures. Subsequently, through the
remainder of this article, such TCD-based measures will be referred
to as cerebrovascular reactivity metrics.
Since then, a significant amount of research has been
undertaken to examine the association between continuous
TCD based indices of cerebrovascular reactivity and outcomes
following TBI (It should be noted that cerebrovascular reactivity
and CA are not entirely interchangeable as cerebrovascular
reactivity can occur outside the limits of autoregulation.
Cerebrovascular reactivity is the broader term that describes the
physiologic process that is measured by these indices). Slightly
modified indices that used the diastolic and systolic FV were
examined (Dx and Sx, respectively) along with indices that
utilized ABP, as opposed to CPP, as the driving force (Mx_a,
Dx_a, and Sx_a). Table 1 summarizes these indices and their
derivation. Notably, those that utilize ABP instead of CPP open the
door to the entirely non-invasive measurement of cerebrovascular
reactivity (Zeiler et al., 2018b; Zeiler et al.,2019b; Zeiler and
Smielewski, 2018; Gomez et al., 2020). This has the potential to
expand their application to the neurocritical care of patient
populations that do not typically have ICP monitoring as well
as to the outpatient setting.While not yet adopted widely in clinical
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practice, these indices have an ever-growing body of evidence
supporting their association with outcomes following TBI. The
development of these indices has renewed the intertest in leveraging
measures of cerebrovascular reactivity in the development of
personalized treatments following TBI. Further to this, adoption of
this continuous non-invasive cerebrovascular reactivity assessment has
expanded outside of TBI, including recent work in subarachnoid
haemorrhage and general operative populations (Budohoski et al.,
2012b; Klein et al., 2019). Thus, to aid with the development of further
prospective studies in both TBI and non-TBI cohorts, a comprehensive
understanding of the association betweenTCDbased continuous time-
domain cerebrovascular reactivity indices with patient-oriented
outcomes is warranted. Given that the majority of the literature to
date is focused in theTBI populations, the naturalfirst step is to provide
a comprehensive scoping overview of the association between TCD
based cerebrovascular reactivity indices with: A. global patient
outcomes, B. other cerebral physiologic correlates, and C. lesion
change/progression on serial imaging. Thus, the aim of this study
was to perform a systematically conducted review of the literature to
evaluate the association between these continuous time-domain TCD
based indices of cerebrovascular reactivity and the above outcomes, in
adult moderate/severe TBI. In doing so, a better understanding of the
role these indices play in describing the post-TBI physiome may be
developed.
METHODS
A systematically conducted scoping review of the available
literature was conducted based on the methodological
framework described by Arksey and O’Malley (2005). The
data was reported in line with the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses Extension for Scoping
Reviews (PRISMA-ScR; Tricco et al., 2018). The search strategy
and methodology used here is similar to other systematically
conducted scoping reviews published by our group (Froese et al.,
2020a, Froese et al.,2020b, Froese et al.,2020c; Hasen et al., 2020).
The review questions and search strategy were decided upon
by the senior author (FAZ) and primary author (AG)
Search Questions, Populations, and
Inclusion/Exclusion Criteria
The question of this systematically conducted scoping review was:
What is the association of continuous time-domain TCD based
indices of cerebrovascular reactivity, with: A. global functional
outcomes, B. cerebral physiologic correlates, and C. imaging
evidence of lesion change following moderate-to-severe TBI?
All English language studies, either prospective or
retrospective, with 20 or more adult (age 18 years or older)
moderate and severe TBI patients, were included. Moderate
TBI is defined as an admission Glasgow coma scale (GCS) of
9–12 while a GCS of 3–8 defines severe TBI.
Only continuous time-domain TCD based cerebrovascular
reactivity metrics were of interest, excluding both intermittent
techniques (Zeiler et al., 2017a) and those based in frequency-
domain (i.e., transfer-function techniques; Czosnyka et al., 2008).
The eligible time-domain TCD based cerebrovascular reactivity
indices of interest were Mx, Sx, Dx, Mx_a, Sx_a, and Dx_a.
Table 1 outlines the components of these indices and their
derivation.
The primary outcome of interest was the statistically
significant association between these indices and morbidity/
mortality following TBI. Secondary outcomes included
statistically significant associations with severity of injury and
age. Additionally, associations with various cerebral physiologic
parameters such as ICP, CPP, brain tissue oxygenation (PbtO2),
and CO2 reactivity were also examined. Give that the pressure
reactivity index (PRx) has become a widely accepted continuous
measures of cerebrovascular reactivity (Czosnyka et al., 1997;
Zeiler et al., 2018d), its associations with TCD based indices were
also collected. Associations between TCD based indices and more
novel ICP based indices of cerebrovascular reactivity, such as PAx
and RAC, were excluded as these indices are not as well
established despite their evidence of their prognostic utility in
TBI (Zeiler et al., 2017b).Table 2 outlines the cerebral physiologic
parameters that were examined for their association with TCD
based indices. All parameters selected as secondary outcomes are
known to be associated with global outcomes and/or are
physiologic targets in guideline based management following
moderate to severe TBI (Carney et al., 2017; Zeiler et al.,
2018d; Hawryluk et al., 2019).
Studies relating to TCD time-domain based cerebrovascular
reactivity measures and imaging changes were searched for.
Specifically, studies examining the association of these indices
with changes in CT score (Marshall, Rotterdam, Helsinki, or
Stockholm), midline shift, and hematoma volume as well as the
development on new lesions were all considered relevant.
Exclusion criteria for studies were the following: non-English,
non-human, non-TBI, mild TBI, paediatric cohorts, non-time-
TABLE 1 | Various transcranial Doppler based Indices of cerebrovascular reactivity with their component signals and derivation.
Index Surrogate for cerebral blood flow Surrogate for driving force Signal averaging (s) Calculation windows (s) Update frequency (min)
Mx Mean CBFV CPP 10 300 1
Sx Systolic CBFV CPP 10 300 1
Dx Diastolic CBFV CPP 10 300 1
Mx_a Mean CBFV ABP 10 300 1
Sx_a Systolic CBFV ABP 10 300 1
Dx_a Diastolic CBFV ABP 10 300 1
ABP, Arterial blood pressure; CBFV, Cerebral blood flow velocity (measured by transcranial Doppler); CPP, Cerebral perfusion pressure.
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domain TCD based indices, non-continuous TCD metrics,
cohort < 20 TBI patients, or no relevant outcome (functional
or physiologic) association. Review studies and meta-analysis
were also excluded from consideration.
Search Strategy
BIOSIS, Cochrane Library, EMBASE, MEDLINE, and SCOPUS
were searched from inception to November 2020 using
individualized search strategies for each database. The search
strategy for SCOPUS can be seen in Supplementary Appendix A
with similar strategies used for each of the other databases.
Finally, the reference lists of each article were reviewed to
ensure no studies were missed. Search results were then
combined, and deduplication was performed.
Study Selections
Using two reviewers (AG and LF) a two-step review of all articles
returned by our search strategies was performed. In the first filter
phase, each reviewer independently screened all studies identified
using the above-described search strategy and determined if they
met the inclusion criteria based on their title and abstract. The
resulting list of studies was then passed through the second filter
phase where once again each reviewer independently determined
if the studies met the inclusion criteria, but this time based on the
full text. Any discrepancies between the two reviewers were
resolved by a third party (FAZ).
Data Collection
Data was extracted from the selected articles and compiled into
various data fields. These fields included the following: number of
patients, study design, institution, mean age, mean GCS on
presentation, number of male patients, additional patient
characteristics, goals of the study, indices examined, duration
of insonation, outcomes evaluated, key results, and conclusions.
Bias Assessment
Given the goal of this review was to provide a comprehensive
scoping overview of the available literature, a formal bias
assessment was not conducted.
Statistical Analysis
Due to the heterogeneity of the results/study design no meta-
analysis was performed.
RESULTS
Search Results and Study Characteristics
The results of the search and filtration strategy can be seen in
Figure 1. Overall, the search strategy identified 617 articles with
296 remaining following deduplication. Following the first
filtration stage, based on article title and abstract, 187 articles
were removed for not fitting into the inclusion/exclusion criteria.
Full text documents were reviewed on the remaining 109 articles
in the second filtration phase with 73 articles being found to not
meet the inclusion/exclusion criteria for this study. This left 36
articles to be included in this scoping review. Figure 1 provides
the PRISMA flow-diagram.
Table 3 summarizes general characteristics of each study while
Table 4 outlines the key results, conclusions, and limitations of
each study. Mx was the most common time-domain TCD index
that was studied, with all but one study reporting on it (Czosnyka






An invasively measured physiologic parameter obtained through either
the placement of an intraparenchymal probe or placement of an
intraventricular catheter. It represents the pressure experienced by the
brain
Following TBI values greater than 20–22 mmHg are associated with
worse outcomes. Current guideline-based management recommends
maintain ICP less than 22 mmHg post injury (Carney et al., 2017)
Cerebral perfusion
pressure (CPP)
This is a derived physiologic parameter equal to the difference between
ABP and ICP. It represents the net pressure gradient that drives oxygen
delivery to the brain
Following TBI values greater than 70 mmHg and less than 60 mmHg
are associated with worse outcomes. Current guideline-based
management recommends maintain CPP between 60 and 70 mmHg
post injury (Carney et al., 2017)
Brain tissue oxygenation
(PbtO2)
An invasively measured physiologic parameter obtained through the
placement of an intraparenchymal Clark electrode. It measures
extracellular oxygen content and is thought to reflect cerebral
oxygenation.
Following TBI values less than 20 mmHg are associated with worse
outcomes. Current guideline-based management recommends
maintain a PbtO2 greater than 20 mmHg (Hawryluk et al., 2019)
CO2 reactivity This is the propensity of the brains vasculature to dilate in the setting of
elevated PaCO2 and constrict in the setting of a reduced PaCO2. It can
be measured in numerous methods, including TCD, and can be
leveraged in the acute management of TBI
Following TBI, if CO2 reactivity is intact, elevated ICP can be treated
transiently with hyperventilation to reduce PaCO2 which reduces CBV
and results in a decrease in ICP (Carney et al., 2017)
Pressure reactivity
index (PRx)
This derived invasive index is a moving Pearson correlation coefficient
between ICP and ABP. It ranges in value from −1.0 to +1.0 and is
thought to represent cerebrovascular reactivity with higher correlation
(and therefore higher vales) being associated with disrupted
cerebrovascular reactivity
Recently it has been found that following moderate-to-severe TBI PRx
values of +0.35 are associated with increased morbidity and mortality
(Zeiler et al., 2018d)
ABP, arterial blood pressure; CBV, cerebral blood volume; CO2, carbon dioxide; CPP, cerebral perfusion pressure; ICP, intracranial pressure; mmHg, millimetres of mercury; PaCO2,
partial pressure of carbon dioxide; PbtO2, brain tissue oxygenation; PRx, pressure reactivity index; TBI, traumatic brain injury; TCD, transcranial doppler.
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et al., 2005). It was also the only index with evidence showing that
it worsened with injury severity (Czosnyka et al., 1996; Czosnyka
et al., 1999; Czosnyka et al., 2000) and with advanced age
(Czosnyka et al., 2005; Czosnyka et al., 2008). The next most
common index was Mx_a with it being measure in nine studies
(Lang et al., 2003a; Lang et al., 2003b; Lewis et al., 2007;
Sorrentino et al., 2011; Budohoski et al., 2012c; Liu et al.,
2015; Zeiler et al., 2017b; Zeiler et al., 2018a; Zeiler et al.,
2018c). Notably, Mx, and Mx_a have been found to be
strongly associated with one another (Schmidt et al., 2003a;
Lewis et al., 2007; Sorrentino et al., 2011). The remainder of
time-domain TCD based indices were examined only in a
minority of studies. The number of patients with TCD
recordings included in each study varied from as few as 20
TBI patients to as many as 347 (Schmidt et al., 2016b; Zeiler
et al., 2018e). It should be noted that only five of the 36 articles did
not report on data from patients at the Addenbrooke’s Hospital in
Cambridge, United Kingdomwith the largest of these studies only
including 40 TBI patients (Lang, 2003; Lang et al., 2003a; Lang
et al., 2003b; Schmidt et al., 2016a; Schmidt et al., 2016b).
Mortality
There is strong evidence of an association between
dysfunctional cerebrovascular reactivity, as measured by
continuous time-domain TCD based indices, and mortality
following TBI, with numerous studies finding a higher Mx
correlating with mortality (Czosnyka et al., 2002; Schmidt.
et al., 2003b; Schmidt. et al., 2016a; Budohoski et al., 2012a;
Budohoski et al., 2012c). A notable exceptions to this was a 2016
study by Schmidt and colleagues which contained a mixed
cohort of 20 TBI patients and 21 non-TBI patients (Schmidt
et al., 2016b).
The evidence for the association between other TCD based
indices and mortality is not as clear with a 2018 study by Zeiler
and colleagues having most comprehensively examined this
relationship in a cohort of 281 TBI patients (Zeiler et al.,
2018a). Sx and Sx_a were found to have the strongest
associations with mortality for indices with CPP and ABP as
inputs, respectively, while Mx and Mx_a were also found to have
some association. Neither Dx nor Dx_a were found to have any
correlation with mortality.
FIGURE 1 | A PRISMA flow-diagram of the systematically conducted scoping review of the literature.
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Global Functional Outcomes
Most studies chose to use Glasgow Outcome Scale (GOS) as their
outcome metric of choice, while opting to dichotomize outcome
into favourable/unfavourable or good/poor (with favourable
typically denoted as GOS of 5 or above and unfavourable as
GOS 4 or less). Follow up was usually collected at 6 months post-
injury. Once again, Mx seems to have the strongest body of
evidence supporting its association with outcomes with studies
consistently finding that a higher Mx was associated with poor or
unfavourable outcome at follow up (Czosnyka et al., 1996;
Czosnyka et al., 1997; Czosnyka et al., 1999; Czosnyka et al.,
2000; Czosnyka et al., 2001; Czosnyka et al., 2002; Czosnyka et al.,
2008; Lang et al., 2003a; Lewis et al., 2007; Lewis et al., 2012;
Radolovich et al., 2011; Sorrentino et al., 2011; Budohoski et al.,
2012a; Budohoski et al., 2012c; Liu et al., 2015; Schmidt et al.,
2016a). When Mx was found to not be associated with outcomes,
it was often attributed to small sample sizes (Schmidt et al., 2016b;
Zeiler et al., 2017b).
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298 with TCD data
Not reported Mx/PRx
ABP, arterial blood pressure; aSAH, aneurysmal subarachnoid haemorrhage; CPP, cerebral perfusion pressure; DAI, diffuse axonal injury; Dx, diastolic flow index with CPP; Dx_a, diastolic
flow index with ABP; EDH, epidural hematoma; ICH, intracerebral haemorrhage; IVH, intraventricular haemorrhage; MLS, midline shift; Mx, mean flow index with CPP; Mx_a, mean flow
index with ABP; PRx, pressure reactivity index; SDH, subdural hematoma; TCD, transcranial doppler; tSAH, traumatic subarachnoid haemorrhage; Sx, systolic flow index with CPP; Sx_a,
systolic flow index with ABP.
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TABLE 4 | Study goals, findings and limitations of included studies.




Primary: To assess the association of Mx
with functional outcomes.
Secondary: To assess the association of
Mx with PRx.
Mx was significantly different between those
that had unfavourable outcomes and those
that had favourable outcomes (0.09 ± 0.26
vs. −0.03 ± 0.25, p  0.002).
Mx was significantly different in those that
died and those that survived (0.12 ± 0.29 vs.
0.01 ±0.25, p  0.018).
Mx and PRx correlated well (r  0.58,
p < 0.01)
Mx was significantly lower in those with
good functional outcomes and those that
survived.
Mx and PRx covary with one another
ABP, ICP and GCS were all significantly
different between those that survived and
those that died, and GCS and ABP were
significantly different between those with
favourable and unfavourable functional
outcomes, but this was not controlled for





Primary: To assess the prognostic utility
of Mx, Sx, Dx, Mx_a, Sx_a, and Dx_a.
Mx (F  16.56, p  0.00006), Sx (F  20.11,
p  0.00001), Dx (F  7.07, p  0.008), Mx_a
(F  8.88, p  0.003), and Sx_a (F  12.49,
p  0.0005) were all able to discriminate
between patients with favourable and
unfavourable functional outcomes at follow
up.
Mx (F  6.93, p  0.009), Sx (F  13.10, p 
0.0003) and Sx_a (F  5.32, p  0.02) were
all able to discriminate between those that
survived and those that did not at follow up
Mx, Sx, Dx, Mx_a, and Sx_a were able to
discriminate between those with favourable
and unfavourable functional outcomes with
Sx having the strongest predictive value
Mx, Sx, and Sx_a were able to discriminate
between survival and death with Sx having
the strongest predictive value
ICP and admission GCS were also found to
be able to discriminate between favourable
vs. unfavourable and death vs. survival but
no multivariant analysis was performed to
identify if the TCD indices had prognostic





Primary: To assess the association of Mx/
Sx with global outcomes.
Secondary: To assess the association of
Mx/Sx with severity of injury, age, CPP
and ICP
Mx (r  0.41, p < 0.0002) and Sx (r  0.48,
p < 0.00009) correlated with 6-month GOS
Mx (r  −0.34, p < 0.0025) and Sx (r  −0.38,
p < 0.0008) correlated with admission GCS
Mx and Sx correlate with both injury severity
and functional outcome




Primary: To assess the prognostic ability
of PRx.
Secondary: To assess the covariance of
PRx and Mx
Mx positively correlated with PRx (r  0.63,
p < 0.000001)
Mx (r  0.41, p < 0.0002) correlated with 6-
month GOS.
Median Mx significantly differed in those
with a favourable vs. unfavourable outcome
(−0.26 vs. 0.03, p < 0.00008)
There is good correlation between Mx and
PRx in non-craniectomy patients
Mx was associated with functional
outcomes at 6 months




Primary: To assess the prognostic ability
of PRx.
Secondary: To assess the correlation of
Mx and PRx
Mx (r  0.41, p < 0.0002) correlated with 6-
month GOS
Mx positively correlated with PRx (r  0.63,
p < 0.000001)
There is good correlation between Mx and
PRx in non-craniectomy patients
Mx was associated with functional
outcomes at 6 months
No multivariate analysis performed




Primary: To assess the correlation Mx
with functional outcomes.
Secondary: To assess the association of
Mx with admission GCS, CPP and ICP
Mx correlated with 6-month GOS (r  0.39,
p < 0.05)
Mx correlated with admission GCS (r 
−0.28, p < 0.05)
Mx correlated with ICP and CPP (r  0.45
and r  −0.34, p < 0.05)
Mx was associated with functional
outcomes at 6 months and injury severity
Mx was associated with both ICP and CPP
No multivariate analysis performed so
unclear if Mx association with outcome is
mediated through association with injury




Primary: To assess the association of Mx
with global functional outcomes
Secondary: To assess the association of
Mx with CPP
Mx was significantly greater in those with an
unfavourable outcome (p < 0.001)
Mx correlated with 6-month GOS and
admission GCS (ANOVA, F value 17 and 15,
p < 0.05)
Mx depended on CPP (ANOVA, p < 0.0001)
and became positive at CPP < 60 mm Hg
Mx was associated with functional
outcomes at 6 months and injury severity
Mx was associated with CPP with a lower
threshold of CPP at 60 mm Hg
No multivariate analysis performed so
unclear if Mx association with outcome is





Primary: To assess the association of Mx
with ICP and CPP
Secondary: To assess the association of
Mx with 6-month outcomes
The relationship between Mx and CPP is
characterized by a U-shaped curve
Mx worsened with increasing ICP with the
steepest rise between 20 and 30 mm Hg
Those with a favourable outcome at
6 months had a lower mean Mx (−0.06 ±
0.26 vs. 0.15 ± 0.31, p < 0.00002), lower
mean ICP (17.0 ± 8.9 vs. 23.0 ± 13, p <
0.003), higher GCS on admission (6 vs. 4,
p < 0.0018) and younger age (27 vs. 32, p <
0.015)
Mx has a U-shaped relationship with CPP
and worsens with increasing ICP
A favourable outcome was associated with
lower Mx, lower ICP, Higher admission
GCS, and younger age
No multivariate analysis performed so
unclear if association of Mx with outcomes





Primary: To assess the association of Mx
and PRx with outcomes
Secondary: To identify a threshold value
for Mx
Those with a favourable outcome had a
lower mean Mx (−0.06 ± 0.26 vs. 0.15 ±
0.31, p < 0.00002), lower mean ICP (17.0 ±
8.9 vs. 23.0 ± 13, p < 0.003), higher GCS on
admission (6 vs. 4, p < 0.0018)
Mx (r  −0.2592, p < 0.0001), PRx (r 
0.278, p < 0.0001), ICP (r  −0.195, p <
0.01) and GCS (r  −0.18, p < 0.014) were
all correlated with 6-month GOS
Thresholds of Mx (0.23) and PRx (0.31)
were found by identifying where the
Mx is associated with 6-month outcomes
with an increased mortality at Mx > 0.23
No multivariate analysis performed so
unclear if association of Mx with outcomes
is mediated through ICP, CPP, admission
GCS, age etc.
Single institution dataset
No assessment of threshold outside of
dataset from which it was developed
(Continued on following page)
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TABLE 4 | (Continued) Study goals, findings and limitations of included studies.
Reference Relevant Goals of the Study Key Relevant Results Conclusion Study Limitation
Kruskal-Wallis test reach its max)
Mortality in those above thresholds
consistently was 47% while those below
threshold had a mortality of 11% (p <
0.0001)
PRx and Mx correlated significantly (r 
0.57, p < 0.00001)
Czosnyka et al.
(2005)
Primary: To assess the association of Sx
with functional outcome
Secondary: To assess the association of
Sx with age
Sx not associated with 6-month GOS in
multiple regression models
Sx was significantly worse with age (r 
0.26, p  0.002)
Sx was not found to be associated with
outcome through multiple regression but
cerebrovascular reactivity did worsen
with age
Single institution dataset
Sx was not evaluated in the entire study
population due to incomplete TCD data
leaving room for a selection bias
Czosnyka et al.
(2008)
Primary: To assess the association of Mx
with functional outcomes
Secondary: To assess the association of
Mx with age, ICP, CPP and
admission GCS
Those with a favourable outcome had a
lower Mx than those with an unfavourable
outcome (−0.12 ± 0.28 vs. 0.21 ± 0.35, p 
0.0062) independent of age
Mx was worse with age (r  0.30, p  0.034)
Mx correlated positively with mean ICP (r 
0.31, p  0.028) and negatively with CPP (r
 −0.33, p  0.016)
There was no association with Mx and GCS
on admission
Mx was found to correlate with functional
outcomes independent of age
Cerebrovascular reactivity, as measured by
Mx, worsened with age and ICP while
improving with increasing CPP. It was not
associated with injury severity





Primary: To assess the association of Mx
and Mx_a with functional outcomes at
discharge
Mx_a was associated with outcome ( r 
−0.42, p < 0.05)
Mx was associated with outcome (r −0.56,
p < 0.01)
Mx and Mx_a did not correlated with ABP,
CPP, ICP and CBFV




No indication of duration of insonation
Lang et al.
(2003b)
Primary: The incidence of hemispheric
asymmetry (a difference of Mx_a > 0.2)
and its association with outcome
Hemispheric asymmetry had no impact
on outcomes at discharge
12 of the 25 patients had a hemispheric
asymmetry in Mx_a
Hemispheric asymmetry in cerebrovascular
reactivity is relatively common following TBI
but its impact on outcomes is unclear
No long-term follow-up
Single institution dataset
Very short duration of insonation
Lewis et al.
(2007)
Primary: To assess the association of Mx
and Mx_a with functional outcomes
Secondary: To assess the covariance of
Mx and Mx_a
There was no statistical association
between outcome and Mx_a
Mx was significantly different in those with a
favourable vs. unfavourable outcome
(−0.072 ± 0.21 vs. 0.12 ± 0.24, p  0.007)
Mx and Mx_a were associated with each
other (r  0.71, p < 0.05)
While Mx was associated with functional
outcomes Mx_a was not
Mx and Mx_a were found to be associated
with one another
No multivariate analysis performed so
unclear if association of Mx with outcomes





Primary: To assess the association of Mx
with functional outcome
Secondary: To assess the relationship
between Mx and CPP
Mx was statistically different across GOS at
6 months (F  5.39, p  0.0013)
Mx was able to discriminate between those
with a favourable and unfavourable
functional outcome (F  14.2, p  0.0002)
Plotting Mx vs. CPP shows a U-shaped
curve indicating a CPP at which Mx is at a
minimum
Mx is associated with functional outcomes
There is a U-shaped relationship between
Mx and CPP indicating the possibility to
identify a CPPopt
No multivariate analysis performed so
unclear if association of Mx with outcomes
is mediated through ICP, CPP, admission
GCS, age etc.
No reporting on the relationship between
CPP and Mx in individual patients
Liu et al. (2015) Primary: To assess the association of Mx
Mx_a with functional outcomes
Mx was significantly different in those with
favourable vs. unfavourable outcomes
(−0.04 ± 0.29 vs. 0.09 ± 0.28 respectively,
p < 0.0001, F value15.38, AUC  0.647)
Mx_a was significantly different in those with
favourable vs. unfavourable outcomes
(0.18 ± 0.24 vs. 0.26 ± 0.21, respectively,
p0.002, F value  10.08, AUC  0.627)
Mx_a andMxwere both able to discriminate
favourable vs. unfavourable functional
outcomes but Mx had the stronger
association with outcomes than Mx_a
No multivariate analysis performed so
unclear if association of Mx/Mx_a with
outcomes is mediated through ICP, CPP,




Primary: To assess the prognostic ability
of Mx
Mx was strongly predictive of poor
functional outcome (AUC  0.69, p < 0.001)
Mx was predictive of poor functional
outcome
No multivariate analysis performed so
unclear if association of Mx with outcomes
is mediated through ICP, CPP, admission
GCS, age etc.
Single institution dataset
Significantly variable duration of insonation
Schmidt et al.
(2016a)
Primary: To assess the association of Mx
with functional outcomes following TBI
Secondary: To assess the correlation of
Mx with PRx
Mx correlated with 3-month GOS (r  −0.54,
p < 0.005)
Mx was higher in the non-survivor group
compared to the survivor group (0.28 ± 0.4
vs. 0.03 ± 0.21, p  0.04)
PRx and Mx correlated (r  0.56, p < 0.001)
Mx was associated with functional outcome
and survival following TBI
Mx and PRx correlate positively with one
another
No multivariate analysis performed so
unclear if association of Mx with outcomes






Primary: Examine the association of Mx
and PRx with mortality and functional
outcomes
Mx was not significantly different between
those that died in hospital and those that
survived
Mx and not PRx was significantly different
Mx was not able to predict mortality and but
was significantly different in those with good
functional outcomes compared with those
with poor functional outcomes
No multivariate analysis performed
Single institution dataset
Heterogenous patient population
(Continued on following page)
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Reference Relevant Goals of the Study Key Relevant Results Conclusion Study Limitation
Secondary: To identify a critical threshold
for Mx
between those with a good outcome vs.
those with a poor outcome (−0.07 ± 0.21 vs.
0.21 ± 0.27, p < 0.005)
In the subgroup of TBI patients PRx
correlated with 3-month functional outcome
(r  0.63, p < 0.01) while Mx did not
Mx of 0.2 was found to be a critical
threshold for poor outcome (p <0.005)
Mx has a critical threshold of 0.2 for poor
outcomes
Mx was not associated with functional
outcomes in the subgroup of TBI patients
Sorrentino
et al. (2011)
Primary: To identify a threshold value for
Mx and Mx_a where survival and
functional outcomes worsen
Secondary: To assess the association of
Mx and Mx_a with functional outcomes
and each other
The threshold (by 2x2 chi square analysis)
was 0.3 for survival and good functional
outcome for Mx_a
For Mx, 0.05 was found to be the threshold
for good functional outcome while 0.3 was
the threshold for survival
Mx and Mx_a were both negatively
correlated with outcomes (r  −0.2, p < 0.01
and r  −0.15, p  0.01, respectively)
Mx was significantly correlated with Mx_a (r
 0.78, p < 0.001)
Mx has a threshold for worsening survival at
0.3 while outcomes worsen above 0.05
Mx_a has a single threshold for worsening
survival and poor outcomes at 0.3
Mx and Mx_a are correlated with one
another and both are associated with
functional outcome
No multivariate analysis performed so
unclear if association of Mx with outcomes
is mediated through ICP, CPP, admission
GCS, age etc.
Single institution dataset
No evaluation of thresholds outside of
dataset used to derive them
Zeiler et al.
(2017b)
Primary: To assess the covariance of
various indices of cerebrovascular
reactivity
Secondary: To assess the association of
various indices of cerebrovascular
reactivity and functional outcome
Mx correlated well with Dx (r 0.991, p <
0.0001) and Sx (r  0.726, p < 0.0001)
Mx correlated moderately with PRx
Sx and Sx_a correlated well with ICP based
indices such as PRx
Mx, Sx, and Dx were correlated with Mx_a,
Dx_a and Sx_a strongly
Dx and Dx_a only strongly correlated with
Mx and Sx
No statistically significant association with
functional outcomes was found for any of
the indices
CPP based TCD indices correlated well with
one another
Sx and Sx_a correlated most significantly
with PRx
CPP based and ABP based TCD indices
correlate strongly
No association with functional outcomewas
found likely due to small sample size
No multivariate analysis performed
Single institution dataset




Primary: To confirm the covariance of
TCD and ICP derived indices such at PRx
Secondary: To identify thresholds for Sx,
Sx_a, Dx, and Dx_a associated with
functional outcomes
Sx and Sx_a displays the strongest
correlation with ICP based indices
compared to other TCD based indices
Principle Component Analysis also found Sx
and Sx_a to be most associated with ICP
based indices
Sx and Sx_a also co-clustered with ICP
based indices by Agglomerative Hierarchal
Clustering and K-Means Cluster Analysis
Sx was able to discriminate between alive/dead
(AUC  0.630, p  0.005) and favourable/
unfavourable (AUC  0.646, p  0.001) by
univariate logistic regression and performed
better than Dx and Mx
Sx was found to have a critical threshold of
−0.15 for unfavourable outcome (p< 0.001) and
−0.20 formortality (p<0.0001)bysequential chi-
square thresholding
Sx_a was able to discriminate between alive/
dead (AUC  0.582, p  0.068) and favourable/
unfavourable (AUC  0.632, p  0.001) by
univariate logistic regression and performed
better than Dx_a and Mx_a
Sx_a was found to have a critical threshold of
−0.10 for unfavourable outcome (p  0.0001)
and +0.05 for mortality (p  0.019) by sequential
chi-square thresholding
Chi-square values of Sx were higher than for
Sx_a in thresholding analysis indicating a
stronger relationship between thresholds and
outcomes for Sx than Sx_a
Dx was able to discriminate between
favourable/unfavourable outcomes (AUC 
0.592, p  0.012) but failed to reach
significance when predicting mortality by
univariate logistic regression
Dxwas found to have a threshold of −0.10 (p 
0.005) for unfavourable outcomes
Dx_a failed to reach significance for 6-month
outcomes and mortality
Sx and Sx_a seem to be the most strongly
associated with ICP indices of all TCD
based indices
Sx outperformed Mx and Dx are
discriminating between alive/dead and
favourable/unfavourable outcomes
Sx has a critical threshold at −0.15 for
unfavourable functional outcome and −0.20
for mortality
Sx_a outperformed Mx_a and Dx_a at
discriminating between alive/dead and
favourable/unfavourable functional
outcomes
Sx_a has a critical threshold at −0.10 for
unfavourable outcome and +0.05 for
mortality
Sx was superior to Sx_a when predicting
functional outcome
Dx was only found to be able to discriminate
between favourable and unfavourable
outcomes with a threshold of −0.10
Dx_a failed to display any prognostic value
No multivariate analysis performed
Single institution dataset
Cerebral physiologic correlates
(Continued on following page)
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Primary: To evaluate the relationship
between Mx and ICP, CPP and ABP
Secondary: The examine the association
between hemispheric differences in Mx
and imaging findings on admission and
mortality
The relationship between Mx and ABP or
CPP was U-shaped
Mx was disturbed when CPP < 65 mmHg
and > 90 mmHg and when ICP > 25 mmHg
Mx was > 0.2 during plateau waves of ICP
Mx was significantly worse on the side of the
contusion and on the side of brain expansion in
patients with MLS (p < 0.05)
Hemispheric differences in Mx were more
significantandmorecommon in those thatdied in
hospital
Mx can be used to identify a range of CPP or
ABP over which cerebrovascular reactivity is
most intact
Cerebrovascular reactivity, as measured by
Mx, is disrupted during plateau waves of
ICP
Hemispheric difference in injury can be
detected by Mx and is prognostically
relevant
No assessment of association of
cerebrovascular reactivity and progression
of radiographic findings
Single institution dataset




Primary: To assess if CPPopt, as
determined by Mx, was altered by
hypocapnia
Secondary: To assess if hypocapnia
alters the ability to detect CPPopt withMx
Hypocapnia improved cerebrovascular
reactivity in those where it was impaired (Mx
> 0.25) (left: 0.33 ± 0.149; right: 0.37 ±
0.24 vs. left: 0.06 ± 0.27; right: −0.001 ±
0.17, p < 0.001)
Hypocapnia did not change
cerebrovascular reactivity in those where it
was intact (Mx < 0.25)
Hypocapnia increased the number of
patients for which a CPPopt was identified
from 12 to 29
There was no significant change in CPPopt
at normocapnia or hypocapnia
In those with impaired cerebrovascular
reactivity, hyperventilation improves Mx
In those with intact cerebrovascular
reactivity, hyperventilation did not
significantly change Mx
Hypocapnia seems to not affect CPPopt but
may aid its detection
Single institution dataset




Primary: To assess the impact of
hypocapnia on Mx.
No significant change in Mx was seen with
hypocapnia in those with intact
cerebrovascular reactivity as defined by Mx
< 0.25
In patients with impaired cerebrovascular
reactivity, as defined by Mx > 0.25,
hypocapnia significantly reduces Mx (0.37 ±
0.13 to 0.12 ± 0.25, p < 0.01)
In those with impaired cerebrovascular
reactivity, hyperventilation improves Mx
In those with intact cerebrovascular




Lang (2003) Primary: To assess the association of Mx
with PRx.
Therewasasignificantoverall correlationbetween
PRx and Mx (Pearson correlation, r  0.42, p <
0.007, Spearman correlation, r  0.43, p < 0.05)
Mx and PRx correlate with one another. Single institution dataset
No indication of duration of insonation
Lewis et al.
(2014)
Primary: To evaluate the behavior of Mx
during plateau waves of ICP
Mx during plateau wave was significantly
more positive when compared to pre-
plateau and post-plateau recordings (0.91
vs. 0.27 and 0.29, p  0.001)
Cerebrovascular reactivity, as measured by
Mx, is significantly disrupted during plateau
waves of ICP.
Small number of events observed.
Liu et al. (2016) Primary: To evaluate the behavior of Mx
and Mx_a during plateau waves of ICP
Mx increased from 0.12 ± 0.40 at baseline
to 0.47 ± 0.47 at plateau p  0.004
No significant difference was found
between Mx_a at baseline and at plateau
The deterioration of cerebrovascular
reactivity during plateau waves of ICP was
detected by Mx but not Mx_a
Small number of events observed
Schmidt et al.
(2003a)
Primary: To assess the association of Mx
with Mx_a
Mx and Mx_a correlated well with one
another (r  0.86, p < 0.001)
Mx and Mx_a correlate with one another No indication of duration of insonation




Primary: To assess the prognostic value
of hemispheric asymmetry in Mx
Absolute left to right difference in Mx was
correlated with Mx (mean left-right) (r  0.24,
p < 0.025)
Asymmetry was higher in those that died
than survived (0.14 ± 0.18 vs. 0.08 ± 0.1,
p  0.04)
Mx was higher in those that died (0.13 ±
0.05 vs. −0.03 ± 0.05, p  0.002)
By multiple regression analysis outcome
was independently correlated with
asymmetry of Mx (p < 0.0015)
Hemispheric asymmetry in Mx was





Primary: The assess if Mx/Mx_a were
different during increases of CPP than
during decreases of CPP
Mx was significantly different during
increases of CPP than during decreases of
CPP (0.05 ± 0.49 vs. 0.14 ± 0.54, p < 0.005)
Mx_a was not significantly different during
increases in CPP compared to decreases
in CPP
Cerebrovascular reactivity, as measured by
Mx, appears to be stronger during increases
in CPP than during decreases in CPP
During analysis, a large proportion of data
was discarded with data from 53 out of 210
patients used in the study
Schmidt et al.
(2012)
Primary: To evaluate if cerebrovascular
reactivity differs during increases in CPP
as compared to decreases in CPP
Cerebrovascular reactivity, as measured by
Mx, was stronger during increases in CPP
compared to decreases in CPP (0.06 ± 0.52
vs. 0.15 ± 0.55, p < 0.005)
Cerebrovascular reactivity appears to be
stronger during increases of CPP than
during decreases of CPP
Data used in study represented only a small
amount of original dataset due to limited
availability of TCD recordings
(Continued on following page)
Frontiers in Pharmacology | www.frontiersin.org July 2021 | Volume 12 | Article 69092112
Gomez et al. TCD Cerebrovascular Reactivity in TBI
Once again, the evidence supporting other TCD based indices is
not as prevalent. Mx_a was found to be associated with global
functional outcomes in four different articles with higher values
being associated with worse outcomes (Lang et al., 2003a; Sorrentino
et al., 2011; Liu et al., 2015; Zeiler et al., 2018a). Dx and Dx_a have
been more recently examined with Dx having a weak association
with functional outcomes and Dx_a failing to demonstrate any
predictive value. In the original 1996 study by Czosnyka and
colleagues Sx was correlated with 6-month GOS (Czosnyka et al.,
1996). More recently, Sx and Sx_a have been found to be the most
strongly correlatedwith outcome of those indices with CPP andABP
as inputs, respectively, (Zeiler et al., 2018a). Of note, a 2005 study by
Czosnyka and colleagues found that Sx was not associated with
functional outcome when utilizing a multiple regression model
including ICP and age (Czosnyka et al., 2005).
Thresholds
Thresholds values of indices, where outcomes or mortality
significantly increases, was the focus of 4 articles. In a 2002
study by Czonyka and colleagues they found a threshold for
Mx of 0.23, above which mortality went from 11 to 47%
(Czosnyka et al., 2002). A similar threshold for mortality, Mx 
0.3, was found in a follow up study by Sorrentino and colleagues in
2011. In that same study, a threshold of 0.05 forMxwas found to be
where functional outcomes most drastically worsened while
Schmidt and colleagues found a threshold for unfavourable
outcomes closer to that of the mortality threshold at Mx  0.2
(Sorrentino et al., 2011; Schmidt et al., 2016b).
In the 2011 study by Sorrentino and colleagues, Mx_a was
found to have a threshold at 0.3 where both mortality and
functional outcome both worsened in their cohort (Sorrentino
et al., 2011). Zeiler and colleagues found in 2018 that in their cohort
of 281 TBI patients, Sx had thresholds of −0.15 and −0.20 while
Sx_a had thresholds of −0.10 and 0.05 for functional outcome and
mortality, respectively. They also identified a threshold of −0.10 for
Dx where outcomes worsened (Zeiler et al., 2018a).
Hemispheric Asymmetry
TCD can be utilized to insonate the left and right MCA of the
patient without any increased risk to the patient and so a number of
studies examined the effect of hemispheric asymmetry of TCD
based indices of cerebrovascular reactivity. Czosnyka and
colleagues noted in their 2003 study that Mx was worse on the
side of contusion or expansion if the patient hadmidline shift. They
also noted that a hemispheric asymmetry was significantly more
common in patients that died than those that survived (Czosnyka
et al., 2003). In a follow up study Schmidt and colleagues found that
the magnitude of hemispheric asymmetry, as determined by Mx,
was higher in patients that died compared to those that survived
and that hemispheric asymmetry was independently associated
with functional outcome by multiple regression analysis (Schmidt
et al., 2003b). Interestingly, hemispheric asymmetry, as determined
by Mx_a was not found to be associated with outcomes by Lang
and colleagues in their 2003 study (Lang et al., 2003b).
Established Measure of Cerebrovascular
Reactivity
Cerebrovascular reactivity is often measured by the fluctuation of
ICP in response to changes in ABP in a more established index
known as the pressure reactivity index (PRx). There has been a
building body of evidence supporting cerebrovascular reactivity, in
the form of PRx, being an important physiologicmeasure in TBI and
so several studies have assessed the covariance of PRx and TCD
based indices (Czosnyka et al., 1997; Czosnyka et al., 2002; Lang,
2003; Zweifel et al., 2008; Budohoski et al., 2012a; Schmidt et al.,
2016a; Zeiler et al., 2017b; Zeiler et al., 2018a; Zeiler et al., 2018c).
Once again, Mx has been the most well examined TCD based index
TABLE 4 | (Continued) Study goals, findings and limitations of included studies.
Reference Relevant Goals of the Study Key Relevant Results Conclusion Study Limitation
Zeiler et al.
(2018c)
Primary: To evaluate the association of
various TCD based indices with ICP
based indices, such as PRx
Mx and PRx were correlated (r  0.346, p 
0.006)
Sx and Sx_a were moderately correlated with
ICP based indices such as PRx
ICP based indices, such as PRx, were found to
be most associated with Sx and Sx_a by
Principal Component Analysis and by
Agglomerative Hierarchal Clustering
PRx and Mx are correlated with one another
Sx and Sx_a showed a stronger association






Primary: To determine if PRx can be
estimated by Mx_a and Sx_a
The model of PRx using Sx_a correlated
well with PRx (r  0.794, 95% CI
0.788–0.799, p < 0.0001)
The model of PRx using Sx_a and Mx_a
correlated well with PRx (r  0.809, 95% CI
0.809−0.819, p < 0.0001)
PRx can be estimated using ABP and TCD
based indices Mx_a and Sx_a
Model development cohort was the same




Primary: To assess the association of Mx
with CO2 reactivity
Secondary: To assess the impact of
Hyperventilation of Mx
CO2 reactivity was correlated with Mx (r 
−0.37, p  0.04)
Mx did not significantly change with
hyperventilation
Cerebrovascular reactivity, as measured by
Mx, is associated with CO2 reactivity
Cerebrovascular reactivity, as measured byMx
was not significantly altered by hyperventilation




Primary: To assess the correlation
between Mx and PRx
There was good correlation between Mx
and PRx (r  0.36, p < 0.001)
Both measures of cerebrovascular
reactivity, Mx and PRx, correlated with one
another.
No indication of duration of insonation
TCD was not available for each patient
Single institution dataset
ABP, arterial blood pressure; CBFV, cerebral blood flow velocity; CPP, cerebral perfusion pressure; CPPopt, optimal CPP, Dx, diastolic flow index with cpp, Dx_a, diastolic flow index with
ABP; GCS, glasgow coma scale; GOS, glasgow outcome scale; ICP, intracranial pressure; Mx, mean flow index with cpp; MLS, midline shift; Mx_a, mean flow index with ABP, PRx,
pressure reactivity index; Sx, systolic flow index with cpp; Sx_a, systolic flow index with ABP
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with eight studies demonstrating some degree of correlation between
Mx and PRx (Czosnyka et al., 1997; Czosnyka et al., 2002; Lang,
2003; Zweifel et al., 2008; Budohoski et al., 2012a; Schmidt et al.,
2016a; Zeiler et al., 2017b; Zeiler et al., 2018c). Despite this, recent
work comparing various TCD based indices found that Sx had the
strongest correlation with PRx (Zeiler et al., 2017b; Zeiler et al.,
2018a; Zeiler et al., 2018c), and both Sx and Sx_a appear to closely
approximate PRx through advanced time-series modeling (Zeiler
et al., 2018e). Finally, utilizing complex time-series analysis, PRx has
been found to be estimated well with Mx_a and Sx_a based models
(Zeiler et al., 2018e).
Cerebral Perfusion Pressure and
Intracranial Pressure
The relationship between TCD based indices and ICP seems to be
somewhat independentwithMxbeing found to be positively correlated
with ICP in early studies and a notable increased in Mx with ICPs
above 20mm Hg (Czosnyka et al., 1999; Czosnyka et al., 2001;
Czosnyka et al., 2003; Czosnyka et al., 2008). Notably, during
measurements of plateau waves of ICP, Mx was greater than the
threshold of 0.2 and significantly more positive than pre-plateau and
post-plateau periods (Czosnyka et al., 2003; Lewis et al., 2014). This
difference during plateau waves was not found in Mx_a (Liu et al.,
2016). The association between TCD indices and CPP is slightly more
complex. While early studies showed a negative correlation between
Mx and CPP(Czosnyka et al., 1999; Czosnyka et al., 2000) subsequent
studies have found that when plotting Mx vs. CPP a U-shaped
distribution is observed (Czosnyka et al., 2001; Czosnyka et al.,
2003; Lewis et al., 2012). This may indicate that an optimal CPP
(CPPopt) may exist where Mx is at a minimum, and therefore
cerebrovascular reactivity may be best preserved, for individual
patients. Cerebrovascular reactivity may then be disrupted both
when CPP is inadequate or insufficient and this has been
postulated as a means of identifying individual CPP targets based
on a CPPopt derived from Mx. Interestingly, some studies have also
found that Mx was significantly lower when CPP was increasing
compared to when it was decreasing and that the correlation between
MxandCPP is stronger during increases inCPP than decreases inCPP
(Schmidt et al., 2009; Schmidt et al., 2012). This may indicate that
current management generally places patients at a CPP less than their
CPPopt.
CO2 Reactivity
A number of smaller studies have explored the relationship between
TCD based indices and hypocapnia as well as CO2 reactivity
(Haubrich et al., 2011; Haubrich et al., 2012; Zhang et al., 2016).
In general, those with disrupted cerebrovascular reactivity (Mx ≥
0.25), moderate hypocapnia seemed to significantly decreased Mx
while those with intact reactivity (Mx ≤ 0.25) saw no significant
change with hypocapnia (Haubrich et al., 2011, Haubrich et al., 2012).
Of note, while less than half of the patients examined had an
identifiable CPPopt at normocapnia, nearly all of them had one
with hypocapnia (Haubrich et al., 2011). In a similar study, Zhang and
colleagues found that CO2 reactivity was correlated with Mx but did
not find any significant changes in Mx with hyperventilation (Zhang
et al., 2016).
Radiographic Evolution of Injury
No study was identified that examined the association between
time-domain TCD based indices of cerebrovascular reactivity and
the evolution of imaging findings following TBI.
DISCUSSION
A strong relationship between time-domain TCD based indices of
cerebrovascular reactivity and mortality/functional outcome
following TBI has been demonstrated through this scoping
review of the literature (Czosnyka et al., 1996; Czosnyka et al.,
1997; Czosnyka et al., 1999; Czosnyka et al., 2000; Czosnyka et al.,
2001; Czosnyka et al., 2002; Lang et al., 2003a; Schmidt et al.,
2003b; Lewis et al., 2007; Radolovich et al., 2011; Sorrentino et al.,
2011; Budohoski et al., 2012a; Budohoski et al., 2012c; Lewis et al.,
2012; Schmidt et al., 2016a). The prognostic utility of TCD based
indices has been emphasized with the identification of thresholds
for most indices at which outcomes worsen and mortality
increases (Czosnyka et al., 2002; Sorrentino et al., 2011;
Schmidt et al., 2016b; Zeiler et al., 2018a). Hemispheric
asymmetry of cerebrovascular reactivity, as measured by TCD
based indices, also seems to pertain a poor prognosis following
TBI (Czosnyka et al., 2003; Lang et al., 2003b; Schmidt et al.,
2003b). There also seems to be a reasonable degree of covariance
between TCD based indices of cerebrovascular reactivity and
more established measures, such as PRx (Czosnyka et al., 1997;
Czosnyka et al., 2002; Lang, 2003; Zweifel et al., 2008; Budohoski
et al., 2012a; Schmidt et al., 2016a; Zeiler et al., 2017b, Zeiler et al.,
2018c). Elevations in ICP seem to be associated with the
disruption of cerebrovascular reactivity (Czosnyka et al., 1999;
Czosnyka et al., 2001; Czosnyka et al., 2003; Czosnyka et al., 2008)
while a U-shape relationship exist between CPP and Mx
indicating the possibility of a CPPopt where cerebrovascular
reactivity is the least disrupted (Czosnyka et al., 2001;
Czosnyka et al., 2003; Lewis et al., 2012). Finally,
hyperventilation seems to improve cerebrovascular reactivity
when it is already disrupted but does not significantly change
it when already intact (Haubrich et al., 2011; Haubrich et al.,
2012; Zhang et al., 2016). These findings highlight the utility of
these indices in not only provided a greater understanding of the
post-TBI physiome but also indicate a role for these measure of
cerebrovascular reactivity in precision medicine by aiding in
developing personalized targets for physiologic parameters
following injury.
This review has also identified some major limitations to this
body of literature. Perhaps, most obvious, is that the
predominance of data supporting these findings comes from a
single institution. This limits the confidence in the
generalizability of these findings. A more subtle corollary of
this is that there is significant overlap in cohorts used over
various articles and so while there may be numerous
publications finding prognostic utility in these indices, the
strength of these finding may be somewhat overstated as the
data is not wholly unique between them.
There are also limitations to the assessment of global outcomes
measured at follow up. None of the studies identified in this
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scoping review utilized pathology specific, detailed quality of life
measures such as the Quality of Life after Brain Injury (QOLIBRI)
instrument. Assessments such as these would have provided a
more comprehensive understanding of a patient’s health-related
quality of life following their injury (von Steinbüchel et al., 2020).
Additionally, trends in functional outcome, identified through
serial measurements collected over multiple timepoints, were not
investigated by any of the studies. As a result, no comments can
be made about the utility of TCD based indices of cerebrovascular
reactivity to stratify various trajectories of functional recovery.
Another weakness is in the analysis performed in these studies.
We have seen that these indices are related to age, severity of
injury and ICP (Czosnyka et al., 2000; Czosnyka et al., 2003;
Czosnyka et al., 2005), however, what is unclear is if these indices
provide prognostic utility independent of these associated
variables as no multivariate analysis was performed. Without
multivariate analysis, the role of TCD based indices as an
independent prognostic tool remains unclear. Further to this,
the studies identified reduced measures of TCD indices to grand
averages over the recording period or over the length of stay with
no study performing time-series analytics to evaluate causal
relationships. While this simplifies analysis, it is at the cost
information encoded in the fluctuations of these indices over a
recording period or over the entire length of stay.
The literature also seems to mainly focus on Mx as the TCD
based index most studied. This is likely due to it being the first
TCD based index described (Czosnyka et al., 1996). While this
means there is a large volume of evidence supporting its use,
studies exploring other indices are limited. Of note, systolic TCD
based indices (Sx and Sx_a) were only examined in seven studies
(Czosnyka et al., 1996; Czosnyka et al., 2005; Budohoski et al.,
2012c; Zeiler et al., 2017b; Zeiler et al., 2018a; Zeiler et al., 2018c;
Zeiler et al., 2018e). This is especially unfortunate given recent
studies finding systolic based indices to closest association with
more established ICP based indices of cerebrovascular reactivity
and provide better prognostic utility than mean flow (Mx and
Mx_a) and diastolic (Dx and Dx_a) TCD based indices(Zeiler
et al., 2018a). Diastolic TCD based indices (Dx and Dx_a) were
only examined in four studies and were found to have the weakest
outcome associations of all modalities (Budohoski et al., 2012c;
Zeiler et al., 2017b; Zeiler et al., 2018a; Zeiler et al., 2018c).
However, generalization of the findings of diastolic (Dx and
Dx_a) and systolic (Sx and Sx_a) modalities are limited not
only by the small number of studies but also due to the fact
that all of the identified studies evaluating them draw from a
single institution’s database (Addenbrooke’s Hospital,
United Kingdom).
There are also some limitations inherent to TCD that become
apparent when reviewing the literature. Due to the difficulty in
obtaining prolonged recordings of TCD data, most studies report
only data collection during a small proportion of time spent in
ICUwith some studies reporting as little as 10 min of insonation a
day (Radolovich et al., 2011) and no study reporting more than
4 h per day. Given the dynamic nature of cerebrovascular
reactivity, as demonstrated by the PRx literature (Adams et al.,
2017), it is hard to believe that prognostic utility would not benefit
from longer periods of insonation. In addition to the variable
duration of insonation, there is also inconsistent timing and rate
of measurements with some studies performing serial daily
measurements (Czosnyka et al., 1996; Czosnyka et al., 1998;
Czosnyka et al., 1999; Czosnyka et al., 2000; Czosnyka et al.,
2001; Czosnyka et al., 2002; Czosnyka et al., 2003; Schmidt et al.,
2003b; Czosnyka et al., 2005; Lewis et al., 2007; Czosnyka et al.,
2008; Radolovich et al., 2011; Sorrentino et al., 2011; Schmidt
et al., 2012; Liu et al., 2015) while others reported only performing
one recording session over the course of admission (Lang et al.,
2003b; Zeiler et al., 2018a; Zeiler et al., 2018c; Zeiler et al., 2018e).
A number of studies also failed to report any details around
duration and frequency of insonation as well as timing of
measurement following injury(Czosnyka et al., 1997; Lang
et al., 2003a; Lang, 2003; Schmidt et al., 2003a; Zweifel et al.,
2008; Schmidt et al., 2009; Budohoski et al., 2012a; Budohoski
et al., 2012c; Lewis et al., 2012; Lewis et al., 2014; Schmidt et al.,
2016a; Schmidt et al., 2016b; Liu et al., 2016; Zhang et al., 2016).
In those studies, in which serial assessments were performed, no
comment was made on the progression of cerebrovascular
reactivity over time.
Finally, there seems to be an absence of any literature
evaluating the link between cerebrovascular reactivity, as
measured by time-domain TCD based indices, and the
evolution or progression of imaging findings in the setting of
TBI. Similar reports have been published with regards to PRx and
have found a link between cerebrovascular reactivity and lesion
progression following TBI (Mathieu et al., 2020a; Mathieu et al.,
2020b; Zeiler et al., 2020). A link between similar TCD based
indices may provide a less invasive means of predicting
radiographic progression and should be explored further.
Limitations
This scoping review does, in and of itself, has some limitations.
Articles included in this study were limited to those that
contained cohorts of greater than 20 TBI patients. This was
done in order to limit the prevalence of small case series and
case reports, however, this may have limited the diversity of
institutions included in this review. Additionally, this review was
limited to continuous time-domain TCD based indices at the
exclusion of frequency domain based TCD indices. While this
was done to avoid excessive heterogeneity in indices examined,
there is evidence that these indices do associate with outcomes
following TBI, but to a lesser degree (Liu et al., 2015).
Additionally, the inclusion articles in journal supplements
resulted in some very similar reports being included in this
review (Haubrich et al., 2011; Haubrich et al., 2012). Finally,
given that TBI has a global burden of disease, the exclusion of
non-English language articles may have further narrowed the
institutional diversity as well as likely skewed the ethnocultural
diversity of the patient cohorts included in this review.
Future Directions
This review highlights some key areas for further development.
First, before TCD based indices are adopted clinically, validation of
these findings will need to occur on more diverse datasets. Large
multi-institutional/multi-national collaborative networks such as
the ones found in the CENTER-TBI study and CAnadian High-
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Resolution TBI (CAHR-TBI) Research Collaborative are ideal for
such validation studies (Bernard et al., 2020). In order to identify the
true prognostic utility of TCD based indices, these studies should
ideally examine the unique contributions of these indices in and
above ICP, age and injury severity through multivariant analysis.
The clinically applicability of these indices may also be
expanded past prognostication. Further exploration of utilizing
TCD based indices to identify personalized CPP targets in
critically ill patients following TBI must be undertaken.
Precision medicine with personalized targets derived from
these indices may provide the means to significantly alter
outcomes following TBI and is already being explored utilizing
more established measure of cerebrovascular reactivity, such as
PRx (Zeiler et al., 2019a).
Further investigation of TCD based indices, aside from Mx,
should also be done given the evidence of the strength of
correlation with outcome Sx has demonstrated. Additionally,
ABP based indices are of particular interest given the recent
description of entirely non-invasive methods of collecting the
requisite physiologic data (Zeiler et al., 2018b; Zeiler et al., 2019b;
Zeiler and Smielewski, 2018; Gomez et al., 2020).
Finally, advances in TCD technology, such as robotic TCD has
allowed for prolonged recording in and above 4 h due to the
continuous robotic optimization of probe position. This has
already been described as a means of assessing cerebrovascular
reactivity for extended periods of time and may extend the
percentage of time monitored while in ICU (Zeiler et al., 2018b;
Zeiler and Smielewski, 2018). This may prove to further improve
the association of these indices with outcomes following TBI while
providing a more complete picture of the post-TBI physiome.
CONCLUSION
This systematic scoping review of the literature identifies that
there is a substantial body of evidence that cerebrovascular
reactivity as measured by time-domain TCD based indices
have prognostic utility following TBI. To a lesser extent, the
literature has also explored some associations between these
indices and cerebral physiologic parameters in this patient
population. Notably, there is lack of evidence evaluating the
correlation between these indices and radiographic progression
following injury. Further research needs to be done to expand the
generalizability of these results and identify optimal inputs and
collection methods for these indices before they can be widely
clinically adopted. However, their role in precision medicine
following traumatic brain injury is promising.
AUTHOR CONTRIBUTIONS
AG: Designed the search strategy and search terms, collected
articles for review, undertook review and screening of the
literature, and prepared the manuscript. LF: Undertook review
and screening of the literature as well as aided in preparing the
manuscript. AS: Aided in preparation of the manuscript. CB:
Aided in preparation of the manuscript. FZ: Responsible for
conceptual development of this article, development of search
strategy, undertook screening of the literature, and aided in
preparation of the manuscript.
FUNDING
FZ receives research support from the Manitoba Public Insurance
(MPI) Neuroscience/TBI Research Endowment, the Health
Sciences Center Foundation Winnipeg, the United States
National Institutes of Health (NIH) through the National
Institute of Neurological Disorders and Stroke (NINDS) (Grant
#: R03NS114335-01), the Canadian Institutes of Health Research
(CIHR) (Grant #: 432061), the Canada Foundation for Innovation
(CFI) (Project #: 38583), Research Manitoba (Grant #: 3906), the
University ofManitoba VPRI Research Investment Fund (RIF), the
University of Manitoba Centre on Aging, and the University of
Manitoba Rudy Falk Clinician-Scientist Professorship. AG is
supported through the University of Manitoba Clinician
Investigator Program. LF is supported through the University of
Manitoba—Department of Surgery GFT Research Grant, and the
University of Manitoba Office of Research Services (ORS)—
University Research Grant Program (URGP). CB is support
through the Center on Aging at the University of Manitoba.
SUPPLEMENTARY MATERIAL




Aaslid, R., Lindegaard, K. F., Sorteberg, W., and Nornes, H. (1989). Cerebral
Autoregulation Dynamics in Humans. Stroke 20, 45–52. doi:10.1161/
01.STR.20.1.45
Aaslid, R., Markwalder, T.-M., and Nornes, H. (1982). Noninvasive Transcranial
Doppler Ultrasound Recording of Flow Velocity in Basal Cerebral Arteries.
J. Neurosurg. 57, 769–774. doi:10.3171/jns.1982.57.6.0769
Aaslid, R. (1986). “The Doppler Principle Applied to Measurement of Blood
Flow Velocity in Cerebral Arteries,” in Transcranial Doppler Sonography.
Editor R. Aaslid (Vienna: Springer Vienna), 22–38. doi:10.1007/978-3-7091-
8864-4_3
Adams, H., Donnelly, J., Czosnyka, M., Kolias, A. G., Helmy, A., Menon, D. K.,
et al. (2017). Temporal Profile of Intracranial Pressure and Cerebrovascular
Reactivity in Severe Traumatic Brain Injury and Association with Fatal
Outcome: An Observational Study. Plos Med. 14, e1002353. doi:10.1371/
journal.pmed.1002353
Arksey, H., and O’Malley, L. (2005). Scoping Studies: towards a Methodological
Framework. Int. J. Soc. Res. Methodol. 8, 19–32. doi:10.1080/
1364557032000119616
Bernard, F., Gallagher, C., Griesdale, D., Kramer, A., Sekhon, M., and Zeiler, F. A.
(2020). The CAnadian High-Resolution Traumatic Brain Injury (CAHR-TBI)
Research Collaborative. Can. J. Neurol. Sci. 47, 551–556. doi:10.1017/cjn.2020.54
Budohoski, K. P., Czosnyka, M., de Riva, N., Smielewski, P., Pickard, J. D., Menon,
D. K., et al. (2012a). The Relationship between Cerebral Blood Flow
Frontiers in Pharmacology | www.frontiersin.org July 2021 | Volume 12 | Article 69092116
Gomez et al. TCD Cerebrovascular Reactivity in TBI
Autoregulation and Cerebrovascular Pressure Reactivity after Traumatic Brain
Injury. Neurosurgery 71, 652–661. doi:10.1227/NEU.0b013e318260feb1
Budohoski, K. P., Czosnyka, M., Smielewski, P., Kasprowicz, M., Helmy, A.,
Bulters, D., et al. (2012b). Impairment of Cerebral Autoregulation Predicts
Delayed Cerebral Ischemia after Subarachnoid Hemorrhage. Stroke 43,
3230–3237. doi:10.1161/STROKEAHA.112.669788
Budohoski, K. P., Reinhard, M., Aries, M. J. H., Czosnyka, Z., Smielewski, P.,
Pickard, J. D., et al. (2012c). Monitoring Cerebral Autoregulation after Head
Injury. Which Component of Transcranial Doppler Flow Velocity Is Optimal?
Neurocrit. Care 17, 211–218. doi:10.1007/s12028-011-9572-1
Carney, N., Totten, A. M., O’Reilly, C., Ullman, J. S., Hawryluk, G. W. J., Bell, M. J.,
et al. (2017). Guidelines for the Management of Severe Traumatic Brain Injury,
Fourth Edition. Neurosurgery 80, 6–15. doi:10.1227/NEU.0000000000001432
Cold, G. E., and Jensen, F. T. (1978). Cerebral Autoregulation in Unconscious
Patients with Brain Injury. Acta Anaesthesiologica Scand. 22, 270–280.
doi:10.1111/j.1399-6576.1978.tb01301.x
Czosnyka, M., Balestreri, M., Steiner, L., Smielewski, P., Hutchinson, P. J., Matta,
B., et al. (2005). Age, Intracranial Pressure, Autoregulation, and Outcome after
Brain Trauma. J. Neurosurg. 102, 450–454. doi:10.3171/jns.2005.102.3.0450
Czosnyka, M., Smielewski, P., Czosnyka, Z., Piechnik, S., Steiner, L. A., Schmidt, E.,
et al. (2003). Continuous Assessment of Cerebral Autoregulation: Clinical and
Laboratory Experience. Acta Neurochirurgica. Suppl. 86, 581–585. doi:10.1007/
978-3-7091-0651-8_118
Czosnyka, M., Smielewski, P., Kirkpatrick, P., Laing, R. J., Menon, D., and Pickard,
J. D. (1997). Continuous Assessment of the Cerebral Vasomotor Reactivity in
Head Injury. Neurosurgery 41, 11–19. doi:10.1097/00006123-199707000-00005
Czosnyka, M., Smielewski, P., Kirkpatrick, P., Menon, D. K., and Pickard, J. D.
(1996). Monitoring of Cerebral Autoregulation in Head-Injured Patients.
Stroke 27, 1829–1834. doi:10.1161/01.STR.27.10.1829
Czosnyka,M., Smielewski, P., Kirkpatrick, P., Piechnik, S., Laing, R., and Pickard, J. D.
(1998). Continuous Monitoring of Cerebrovascular Pressure-Reactivity in Head
Injury. Acta Neurochir. Suppl. 71, 74–77. doi:10.1007/978-3-7091-6475-4_23
Czosnyka, M., Smielewski, P., Lavinio, A., Pickard, J. D., and Panerai, R. (2008). An
Assessment of Dynamic Autoregulation from Spontaneous Fluctuations of
Cerebral Blood Flow Velocity: A Comparison of Two Models, Index of
Autoregulation and Mean Flow Index. Anesth. Analgesia 106, 234–239.
doi:10.1213/01.ane.0000295802.89962.13
Czosnyka, M., Smielewski, P., Piechnik, S., Al-Rawi, P. G., Kirkpatrick, P. J., Matta,
B. F., et al. (1999). Critical Closing Pressure in Cerebrovascular Circulation.
J. Neurol. Neurosurg. Psychiatry 66, 606–611. doi:10.1136/jnnp.66.5.606
Czosnyka, M., Smielewski, P., Piechnik, S., and Pickard, J. D. (2002). Clinical
Significance of Cerebral Autoregulation. Acta Neurochirurgica. Suppl. 81,
117–119. doi:10.1007/978-3-7091-6738-0_30
Czosnyka, M., Smielewski, P., Piechnik, S., Schmidt, E. A., Seeley, H., al-Rawi, P.,
et al. (2000). Continuous Assessment of Cerebral Autoregulation - Clinical
Verification of the Method in Head Injured Patients. Acta Neurochirurgica.
Suppl. 76, 483–484. doi:10.1007/978-3-7091-6346-7_101
Czosnyka, M., Smielewski, P., Piechnik, S., Steiner, L. A., and Pickard, J. D. (2001).
Cerebral Autoregulation Following Head Injury. J. Neurosurg. 95, 756–763.
doi:10.3171/jns.2001.95.5.0756
Froese, L., Dian, J., Batson, C., Gomez, A., Unger, B., and Zeiler, F. A. (2020a).
Cerebrovascular Response to Propofol, Fentanyl, and Midazolam in Moderate/
Severe Traumatic Brain Injury: A Scoping Systematic Review of the Human and
Animal Literature. Neurotrauma Rep. 1, 100–112. doi:10.1089/neur.2020.0040
Froese, L., Dian, J., Gomez, A., Unger, B., and Zeiler, F. A. (2020b). Cerebrovascular
Response to Phenylephrine in Traumatic Brain Injury: A Scoping Systematic
Review of the Human and Animal Literature. Neurotrauma Rep. 1, 46–62.
doi:10.1089/neur.2020.0008
Froese, L., Dian, J., Gomez, A., Unger, B., and Zeiler, F. A. (2020c). The
Cerebrovascular Response to Norepinephrine: A Scoping Systematic Review
of the Animal and Human Literature. Pharmacol. Res. Perspect. 8, e00655.
doi:10.1002/prp2.655
Gomez, A., Batson, C., Froese, L., Sainbhi, A. S., and Zeiler, F. A. (2021). Utility of
Transcranial Doppler in Moderate and Severe Traumatic Brain Injury: A
Narrative Review of Cerebral Physiologic Metrics. J. Neurotrauma [Epub
ahead of print]. doi:10.1089/neu.2020.7523
Gomez, A., Dian, J., and Zeiler, F. A. (2020). Continuous and Entirely Non-invasive
Method for Cerebrovascular Reactivity Assessment: Technique and
Implications. J. Clin. Monit. Comput. 35, 307–315. doi:10.1007/s10877-020-
00472-4
Hasen, M., Gomez, A., Froese, L., Dian, J., Raj, R., Thelin, E. P., et al. (2020).
Alternative Continuous Intracranial Pressure-Derived Cerebrovascular
Reactivity Metrics in Traumatic Brain Injury: a Scoping Overview. Acta
Neurochir 162, 1647–1662. doi:10.1007/s00701-020-04378-7
Haubrich, C., Steiner, L., Kasprowicz, M., Diedler, J., Carrera, E., Diehl, R. R., et al.
(2011). Short-term Moderate Hypocapnia Augments Detection of Optimal
Cerebral Perfusion Pressure. J. Neurotrauma 28, 1133–1137. doi:10.1089/
neu.2010.1577
Haubrich, C., Steiner, L., Kim, D. J., Kasprowicz, M., Smielewski, P., Diehl, R. R.,
et al. (2012). How Does Moderate Hypocapnia Affect Cerebral Autoregulation
in Response to Changes in Perfusion Pressure in TBI Patients? Acta Neurochir
Suppl. 114, 153–156. doi:10.1007/978-3-7091-0956-4_28
Hawryluk, G. W. J., Aguilera, S., Buki, A., Bulger, E., Citerio, G., Cooper, D. J., et al.
(2019). A Management Algorithm for Patients with Intracranial Pressure
Monitoring: the Seattle International Severe Traumatic Brain Injury
Consensus Conference (SIBICC). Intensive Care Med. 45, 1783–1794.
doi:10.1007/s00134-019-05805-9
Klein, S. P., Depreitere, B., and Meyfroidt, G. (2019). How I Monitor Cerebral
Autoregulation. Crit. Care 23, 160. doi:10.1186/s13054-019-2454-1
Lang, E. W. (2003). Cerebral Vasomotor Reactivity Testing in Head Injury: the
Link between Pressure and Flow. J. Neurol. Neurosurg. Psychiatry 74,
1053–1059. doi:10.1136/jnnp.74.8.1053
Lang, E. W., Lagopoulos, J., Griffith, J., Yip, K., Mudaliar, Y., Mehdorn, H. M., et al.
(2003a). Noninvasive Cerebrovascular Autoregulation Assessment in
Traumatic Brain Injury: Validation and Utility. J. Neurotrauma 20, 69–75.
doi:10.1089/08977150360517191
Lang, E. W., Yip, K., Griffith, J., Lagopoulos, J., Mudaliar, Y., and Dorsch, N. W.
(2003b). Hemispheric Asymmetry and Temporal Profiles of Cerebral Pressure
Autoregulation in Head Injury. J. Clin. Neurosci. 10, 670–673. doi:10.1016/
s0967-5868(03)00197-8
Lewis, P. M., Smielewski, P., Pickard, J. D., and Czosnyka, M. (2007). Dynamic
Cerebral Autoregulation: Should Intracranial Pressure Be Taken into Account?
Acta Neurochir (Wien) 149, 549–555. doi:10.1007/s00701-007-1160-y
Lewis, P. M., Smielewski, P., Rosenfeld, J. V., Pickard, J. D., and Czosnyka, M.
(2014). A Continuous Correlation between Intracranial Pressure and Cerebral
Blood Flow Velocity Reflects Cerebral Autoregulation Impairment during
Intracranial Pressure Plateau Waves. Neurocrit. Care 21, 514–525.
doi:10.1007/s12028-014-9994-7
Lewis, P. M., Smielewski, P., Rosenfeld, J. V., Pickard, J. D., and Czosnyka, M.
(2012). Monitoring of the Association between Cerebral Blood Flow Velocity
and Intracranial Pressure. Acta Neurochirurgica. Suppl. 114, 147–151.
doi:10.1007/978-3-7091-0956-4_27
Liu, X., Czosnyka, M., Donnelly, J., Budohoski, K. P., Varsos, G. V., Nasr, N., et al.
(2015). Comparison of Frequency and Time DomainMethods of Assessment of
Cerebral Autoregulation in Traumatic Brain Injury. J. Cereb. Blood FlowMetab.
35, 248–256. doi:10.1038/jcbfm.2014.192
Liu, X., Czosnyka, M., Pickard, J. D., Varsos, G. V., Nasr, N., and Smielewski, P.
(2016). Derangement of Cerebral Blood Flow Autoregulation during
Intracranial Pressure Plateau Waves as Detected by Time and Frequency-
Based Methods. Acta Neurochir. Suppl. 122, 233–238. doi:10.1007/978-3-319-
22533-3_47
Mathieu, F., Zeiler, F. A., Ercole, A., Monteiro, M., Kamnitsas, K., Glocker, B., et al.
(2020a). Relationship between Measures of Cerebrovascular Reactivity and
Intracranial Lesion Progression in Acute Traumatic Brain Injury Patients: A
CENTER-TBI Study. J. Neurotrauma 37, 1556–1565. doi:10.1089/
neu.2019.6814
Mathieu, F., Zeiler, F. A., Whitehouse, D. P., Das, T., Ercole, A., Smielewski, P., et al.
(2020b). Relationship between Measures of Cerebrovascular Reactivity and
Intracranial Lesion Progression in Acute TBI Patients: an Exploratory Analysis.
Neurocrit. Care 32, 373–382. doi:10.1007/s12028-019-00885-3
Overgaard, J., and Tweed, W. A. (1974). Cerebral Circulation after Head Injury.
J. Neurosurg. 41, 531–541. doi:10.3171/jns.1974.41.5.0531
Radolovich, D. K., Aries, M. J. H., Castellani, G., Corona, A., Lavinio, A.,
Smielewski, P., et al. (2011). Pulsatile Intracranial Pressure and Cerebral
Autoregulation after Traumatic Brain Injury. Neurocrit. Care 15, 379–386.
doi:10.1007/s12028-011-9553-4
Frontiers in Pharmacology | www.frontiersin.org July 2021 | Volume 12 | Article 69092117
Gomez et al. TCD Cerebrovascular Reactivity in TBI
Schmidt, B., Czosnyka, M., and Klingelhöfer, J. (2012). Asymmetry of Cerebral
Autoregulation Does Not Correspond to Asymmetry of Cerebrovascular
Pressure Reactivity. Perspect. Med. 1, 285–289. doi:10.1016/
j.permed.2012.02.026
Schmidt, B., Czosnyka, M., Raabe, A., Yahya, H., Schwarze, J. J., Sackerer, D., et al.
(2003a). Adaptive Noninvasive Assessment of Intracranial Pressure and
Cerebral Autoregulation. Stroke 34, 84–89. doi:10.1161/
01.str.0000047849.01376.ae
Schmidt, B., Klingelhöfer, J., Perkes, I., and Czosnyka, M. (2009). Cerebral
Autoregulatory Response Depends on the Direction of Change in Perfusion
Pressure. J. Neurotrauma 26, 651–656. doi:10.1089/neu.2008.0784
Schmidt, B., Lezaic, V., Weinhold, M., Plontke, R., Schwarze, J., and Klingelhöfer, J.
(2016a). Is Impaired Autoregulation Associated with Mortality in Patients with
Severe Cerebral Diseases? Acta Neurochir Suppl. 122, 181–185. doi:10.1007/
978-3-319-22533-3_37
Schmidt, B., Reinhard, M., Lezaic, V., McLeod, D. D., Weinhold, M., Mattes, H.,
et al. (2016b). Autoregulation Monitoring and Outcome Prediction in
Neurocritical Care Patients: Does One index Fit All? J. Clin. Monit.
Comput. 30, 367–375. doi:10.1007/s10877-015-9726-3
Schmidt, E. A., Czosnyka, M., Steiner, L. A., Balestreri, M., Smielewski, P.,
Piechnik, S. K., et al. (2003b). Asymmetry of Pressure Autoregulation after
Traumatic Brain Injury. J. Neurosurg. 99, 991–998. doi:10.3171/
jns.2003.99.6.0991
Sorrentino, E., Budohoski, K. P., Kasprowicz, M., Smielewski, P., Matta, B., Pickard,
J. D., et al. (2011). Critical Thresholds for Transcranial Doppler Indices of
Cerebral Autoregulation in Traumatic Brain Injury. Neurocrit. Care 14,
188–193. doi:10.1007/s12028-010-9492-5
Steinmeier, R., Hofmann, R. P., Bauhuf, C., Hübner, U., and Fahlbusch, R. (2002).
Continuous Cerebral Autoregulation Monitoring by Cross-Correlation
Analysis. J. Neurotrauma 19, 1127–1138. doi:10.1089/08977150260337949
Tricco, A. C., Lillie, E., Zarin, W., O’Brien, K. K., Colquhoun, H., Levac, D., et al.
(2018). PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and
Explanation. Ann. Intern. Med. 169, 467–473. doi:10.7326/M18-0850
Varsos, G. V., Budohoski, K. P., Kolias, A. G., Liu, X., Smielewski, P., Varsos, V. G.,
et al. (2014). Relationship of Vascular wall Tension and Autoregulation
Following Traumatic Brain Injury. Neurocrit. Care 21, 266–274. doi:10.1007/
s12028-014-9971-1
von Steinbüchel, N., Meeuwsen, M., Zeldovich, M., Vester, J. C., Maas, A.,
Koskinen, S., et al. (2020). Differences in Health-Related Quality of Life
after Traumatic Brain Injury between Varying Patient Groups: Sensitivity of
a Disease-specific (QOLIBRI) and a Generic (SF-36) Instrument.
J. Neurotrauma 37, 1242–1254. doi:10.1089/neu.2019.6627
Zeiler, F. A., Cardim, D., Donnelly, J., Menon, D. K., Czosnyka, M., and Smielewski,
P. (2018a). Transcranial Doppler Systolic Flow Index and ICP-Derived
Cerebrovascular Reactivity Indices in Traumatic Brain Injury.
J. Neurotrauma 35, 314–322. doi:10.1089/neu.2017.5364
Zeiler, F. A., Czosnyka, M., and Smielewski, P. (2018b). Optimal Cerebral
Perfusion Pressure via Transcranial Doppler in TBI: Application of Robotic
Technology. Acta Neurochir 160, 2149–2157. doi:10.1007/s00701-018-3687-5
Zeiler, F. A., Donnelly, J., Calviello, L., Menon, D. K., Smielewski, P., and Czosnyka,
M. (2017a). Pressure Autoregulation Measurement Techniques in Adult
Traumatic Brain Injury, Part I: A Scoping Review of Intermittent/Semi-
Intermittent Methods. J. Neurotrauma 34, 3207–3223. doi:10.1089/
neu.2017.5085
Zeiler, F. A., Donnelly, J., Cardim, D., Menon, D. K., Smielewski, P., and Czosnyka,
M. (2018c). ICP versus Laser Doppler Cerebrovascular Reactivity Indices to
Assess Brain Autoregulatory Capacity. Neurocrit. Care 28, 194–202.
doi:10.1007/s12028-017-0472-x
Zeiler, F. A., Donnelly, J., Menon, D. K., Smielewski, P., Zweifel, C., Brady, K., et al.
(2017b). Continuous Autoregulatory Indices Derived from Multi-Modal
Monitoring: Each One Is Not like the Other. J. Neurotrauma 34,
3070–3080. doi:10.1089/neu.2017.5129
Zeiler, F. A., Donnelly, J., Smielewski, P., Menon, D. K., Hutchinson, P. J., and
Czosnyka, M. (2018d). Critical Thresholds of Intracranial Pressure-Derived
Continuous Cerebrovascular Reactivity Indices for Outcome Prediction in
Noncraniectomized Patients with Traumatic Brain Injury. J. Neurotrauma
35, 1107–1115. doi:10.1089/neu.2017.5472
Zeiler, F. A., Ercole, A., Cabeleira, M., Carbonara, M., Stocchetti, N., Menon, D. K.,
et al. (2019a). Comparison of Performance of Different Optimal Cerebral
Perfusion Pressure Parameters for Outcome Prediction in Adult Traumatic
Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research
in Traumatic Brain Injury (CENTER-TBI) Study. J. Neurotrauma 36,
1505–1517. doi:10.1089/neu.2018.6182
Zeiler, F. A., Mathieu, F., Monteiro, M., Glocker, B., Ercole, A., Beqiri, E., et al.
(2020). Diffuse Intracranial Injury Patterns Are Associated with Impaired
Cerebrovascular Reactivity in Adult Traumatic Brain Injury: A CENTER-
TBI Validation Study. J. Neurotrauma 37, 1597–1608. doi:10.1089/
neu.2019.6959
Zeiler, F. A., and Smielewski, P. (2018). Application of Robotic Transcranial
Doppler for Extended Duration Recording in Moderate/severe Traumatic
Brain Injury: First Experiences. Crit. Ultrasound J. 10, 16. doi:10.1186/
s13089-018-0097-0
Zeiler, F. A., Smielewski, P., Donnelly, J., Czosnyka, M., Menon, D. K., and Ercole,
A. (2018e). Estimating Pressure Reactivity Using Noninvasive Doppler-Based
Systolic Flow Index. J. Neurotrauma 35, 1559–1568. doi:10.1089/neu.2017.5596
Zeiler, F. A., Smielewski, P., Stevens, A., Czosnyka, M., Menon, D. K., and Ercole,
A. (2019b). Non-Invasive Pressure Reactivity Index Using Doppler Systolic
Flow Parameters: A Pilot Analysis. J. Neurotrauma 36, 713–720. doi:10.1089/
neu.2018.5987
Zhang, Y., Liu, X., Steiner, L., Smielewski, P., Feen, E., Pickard, J. D., et al. (2016).
Correlation between Cerebral Autoregulation and Carbon Dioxide Reactivity in
Patients with Traumatic Brain Injury. Acta Neurochir. Suppl. 122, 205–209.
doi:10.1007/978-3-319-22533-3_41
Zweifel, C., Lavinio, A., Steiner, L. A., Radolovich, D., Smielewski, P., Timofeev, I.,
et al. (2008). Continuous Monitoring of Cerebrovascular Pressure Reactivity in
Patients with Head Injury. FOC 25, E2. doi:10.3171/FOC.2008.25.10.E2
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 Gomez, Froese, Sainbhi, Batson and Zeiler. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with
these terms.
Frontiers in Pharmacology | www.frontiersin.org July 2021 | Volume 12 | Article 69092118
Gomez et al. TCD Cerebrovascular Reactivity in TBI
